These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12567904)

  • 21. Leptin as a neuroprotective agent.
    Tang BL
    Biochem Biophys Res Commun; 2008 Apr; 368(2):181-5. PubMed ID: 18222172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotection and enhancement of neurite outgrowth with small molecular weight compounds from screens of chemical libraries.
    Dwyer DS; Dickson A
    Int Rev Neurobiol; 2007; 77():247-89. PubMed ID: 17178477
    [No Abstract]   [Full Text] [Related]  

  • 23. FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T.
    Gerard M; Debyser Z; Desender L; Baert J; Brandt I; Baekelandt V; Engelborghs Y
    J Neurochem; 2008 Jul; 106(1):121-33. PubMed ID: 18346205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intracellular domain of amyloid precursor protein interacts with FKBP12.
    Liu FL; Liu PH; Shao HW; Kung FL
    Biochem Biophys Res Commun; 2006 Nov; 350(2):472-7. PubMed ID: 17011518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective role for carbonyl reductase?
    Maser E
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1019-22. PubMed ID: 16406002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congo red and protein aggregation in neurodegenerative diseases.
    Frid P; Anisimov SV; Popovic N
    Brain Res Rev; 2007 Jan; 53(1):135-60. PubMed ID: 16959325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuron damage and protection. Introduction.
    Hu G
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):564-5. PubMed ID: 22490086
    [No Abstract]   [Full Text] [Related]  

  • 28. New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm.
    Peri A; Danza G; Benvenuti S; Luciani P; Deledda C; Rosati F; Cellai I; Serio M
    Front Neuroendocrinol; 2009 Jul; 30(2):119-29. PubMed ID: 19351544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estradiol replacement increases the low-density lipoprotein receptor related protein (LRP) in the mouse brain.
    Cheng X; McAsey ME; Li M; Randall S; Cady C; Nathan BP; Struble RG
    Neurosci Lett; 2007 Apr; 417(1):50-4. PubMed ID: 17346883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial mechanisms of estrogen neuroprotection.
    Simpkins JW; Dykens JA
    Brain Res Rev; 2008 Mar; 57(2):421-30. PubMed ID: 17512984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Turning down, but not off.
    Lipton SA
    Nature; 2004 Apr; 428(6982):473. PubMed ID: 15057811
    [No Abstract]   [Full Text] [Related]  

  • 33. [The concept of neuroprotective agents as a treatment modulator in the development of brain diseases].
    Bordet R; Lestage P; Onteniente B;
    Therapie; 2007; 62(6):463-72. PubMed ID: 18316011
    [No Abstract]   [Full Text] [Related]  

  • 34. The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Blumenfeld Z
    J Neurochem; 2007 Nov; 103(3):962-71. PubMed ID: 17680997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis.
    Poon HF; Shepherd HM; Reed TT; Calabrese V; Stella AM; Pennisi G; Cai J; Pierce WM; Klein JB; Butterfield DA
    Neurobiol Aging; 2006 Jul; 27(7):1020-34. PubMed ID: 15996793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions.
    Exp Biol Med (Maywood); 2008 Nov; 233(11):vi. PubMed ID: 18957631
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection.
    Ganel R; Ho T; Maragakis NJ; Jackson M; Steiner JP; Rothstein JD
    Neurobiol Dis; 2006 Mar; 21(3):556-67. PubMed ID: 16274998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection in progressive brain disorders.
    Djaldetti R; Lev N; Melamed E
    Isr Med Assoc J; 2003 Aug; 5(8):576-80. PubMed ID: 12929297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition.
    Youdim MB; Bar Am O; Yogev-Falach M; Weinreb O; Maruyama W; Naoi M; Amit T
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):172-9. PubMed ID: 15573406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effects of ginsenosides.
    Rausch WD; Liu S; Gille G; Radad K
    Acta Neurobiol Exp (Wars); 2006; 66(4):369-75. PubMed ID: 17265697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.